MPR delivers practical, up-to-date drug information to healthcare professionals. Using the expertise gained from 25 years of providing point-of-care drug tools, MPR has now created a drug review course exclusively for See below for a list of each quarter's courses. Click here to visit MPR's website.

Latest Courses

Clinical Review

New-Drug Review from MPR (April 2014)

1.00 Credits

MPR Drug News

Can Education Boost Adherence to Apixaban? New Data Presented

Research presented at the European Society of Cardiology Congress 2015 reports that an education program did not improve adherence to apixaban among patients with atrial fibrillation (AF) compared to usual information about the disease and treatment.

Sensus Wearable Device for RLS: Pilot Study Data Announced

NeuroMetrix announced preliminary results from a pilot study on the safety and efficacy of its Sensus Pain Management System in patients with restless leg syndrome (RLS).

Ezetimibe Add-On Tx Shows CV Benefits in Patients With Diabetes, ACS

Ezetimibe added to statin therapy showed a benefit in patients with diabetes who were admitted to the hospital with acute coronary syndrome (ACS), according to a study presented the European Society of Cardiology Congress 2015.

New Guidance for Clinicians on Peanut Introduction, Allergy Risk in Infants

The American Academy of Pediatrics (AAP) has issued interim guidance, in conjunction with 10 other medical organizations, supporting early rather than delayed peanut introduction during the period of complementary food introduction in infants.

Positive Changes Seen With Opioid Continuing Education for Clinicians

New findings confirm that continuing education programs on how to safely prescribe and manage opioid therapy can help lower the prevalence of prescription opioid misuse, according to a study published in the journal Pain Medicine.